These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6056041)

  • 21. Affinity chromatography: purification of bovine trypsin and thrombin.
    Hixson HF; Nishikawa AH
    Arch Biochem Biophys; 1973 Feb; 154(2):501-9. PubMed ID: 4734892
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synthetic serin protease inhibitors. 1. Inhibition of trypsin, plasmin and thrombin by amidino- and guanidinobenzoic acid esters].
    Markwardt F; Walsmann P; Stürzebecher J; Landmann H; Wagner G
    Pharmazie; 1973 May; 28(5):326-30. PubMed ID: 4715051
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relationships between structure and action of primary amines and amino acids in the inhibition of trypsin].
    Mix H; Trettin HJ; Gülzow M
    Hoppe Seylers Z Physiol Chem; 1965; 343(1):52-60. PubMed ID: 5885531
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of proteolytic enzymes by decarboxylated amino-acid derivatives. Effect of toluenesulphonyl(tosyl)agmatine (4-toluenesulphonamidobutyl-guanidine) on thrombin trypsin.
    LORAND L; RULE NG
    Nature; 1961 May; 190():722-3. PubMed ID: 13763480
    [No Abstract]   [Full Text] [Related]  

  • 25. Determiniation of trypsin-inhibitor complex dissociation by use of the active site titrant, p-nitrophenyl p'-guanidinobenzoate.
    Zahnley JC; Davis JG
    Biochemistry; 1970 Mar; 9(6):1428-33. PubMed ID: 5461483
    [No Abstract]   [Full Text] [Related]  

  • 26. [Synthetic inhibitors of serine proteinases. 8. Inhibition of trypsin, plasmin and thrombin by means of amidinophenyl-derivatives with ketonic-structure].
    Stürzebecher J; Markwardt F; Richter P; Voigt B; Wagner G; Walsmann P
    Pharmazie; 1976 Jul; 31(7):458-61. PubMed ID: 135982
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification of carboxyl groups in the binding sites of trypsin with the Meerwein reagent.
    Nakayama H; Tanizawa K; Kanaoka Y
    Biochem Biophys Res Commun; 1970 Aug; 40(3):537-41. PubMed ID: 5492151
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the active center of trypsin. Further characterization of the hydrophobic binding site.
    Mares-Guia M; Shaw E; Cohen W
    J Biol Chem; 1967 Dec; 242(23):5777-81. PubMed ID: 6073659
    [No Abstract]   [Full Text] [Related]  

  • 29. Active derivatives of a polypeptide inhibitor of trypsin (Kunitz and Northrop inhibitor).
    Chauvet J; Acher R
    Biochem Biophys Res Commun; 1967 Apr; 27(2):230-5. PubMed ID: 6035487
    [No Abstract]   [Full Text] [Related]  

  • 30. [Modification of thrombin activity by synthetic serine proteinase inhibitors].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):471-82. PubMed ID: 4121340
    [No Abstract]   [Full Text] [Related]  

  • 31. Trypsin substrates derived from benzamidine: application to active site titration and isolation of acyl-enzyme intermediate.
    Tanizawa K; Ishii SI; Kanaoka Y
    Biochem Biophys Res Commun; 1968 Sep; 32(5):893-7. PubMed ID: 5682313
    [No Abstract]   [Full Text] [Related]  

  • 32. The interaction of trypsin with neutral substrates and modifiers.
    Sanborn BM; Hein GE
    Biochemistry; 1968 Oct; 7(10):3616-24. PubMed ID: 5681468
    [No Abstract]   [Full Text] [Related]  

  • 33. Alkylation of serine at the active site of trypsin.
    Lawson WB; Leafer MD; Tewes A; Rao GJ
    Hoppe Seylers Z Physiol Chem; 1968 Feb; 349(2):251-62. PubMed ID: 5677011
    [No Abstract]   [Full Text] [Related]  

  • 34. The involvement of tyrosyl and amino groups in the interaction of trypsin and a soybean trypsin inhibitor.
    Papaioannou SE; Liener IE
    J Biol Chem; 1970 Oct; 245(19):4931-8. PubMed ID: 5528239
    [No Abstract]   [Full Text] [Related]  

  • 35. Affinity sorbents containing benzamidine derivatives for biomedical application.
    Lasionova NI; Mityushina GV; Beresin IV; Zhuravlyov AG; Voigt B; Wagner G
    Pharmazie; 1984 Nov; 39(11):738-40. PubMed ID: 6531374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthetic inhibitors of serine proteinases. 3. Inhibitory effect of basic ally substituted phenyl carbonic acid esters in comparison with trypsin, plasmin and thrombin].
    Stürzebecher J; Markwardt F; Richter P; Wagner G; Walsmann P; Landmann H
    Pharmazie; 1974 May; 29(5):337-8. PubMed ID: 4277283
    [No Abstract]   [Full Text] [Related]  

  • 37. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract]   [Full Text] [Related]  

  • 38. [Quantum chemical studies on substituted benzamidines as inhibitors of the serine proteinases trypsin and thrombin].
    Henkel HJ; Labes D; Hagen V
    Pharmazie; 1983 May; 38(5):342-6. PubMed ID: 6611634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of acrosin by benzamidines.
    Stürzebecher J
    Acta Biol Med Ger; 1981; 40(10-11):1519-22. PubMed ID: 7044006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the active site of trypsin. I. The reaction of trypsin with the specific inhibitor n-alpha-tosyl-l-lysyl-chloromethane and certain pseudosubstrates.
    Severin ES; Tomásek V
    Biochem Biophys Res Commun; 1965 Aug; 20(4):496-502. PubMed ID: 5860167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.